In bladder cancer, genes involved in Wnt signaling are rarely mutated but epigenetic deregulation and deletion of sFRP1, coding for a Wnt pathway antagonist, has been reported in 25% of tumors36. Here, SFRP1 is linked to urinary bladder cancer.